Login
$CERO
$0.10 +$0.00 (0.0%) Close

Insider Transactions

What CERo Therapeutics Holdings Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 0 0
Total trades 0 0

Shares traded

3 months 12 months
Acquired 0 0
Disposed 0 0
Net activity +0 +0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Atwood Brian G Director Mar 31 Exercise / conversion · M +294,460 $0.00 +$29.4 490,534
Yk Bioventures Opportunities Gp I, Llc 10% owner Dec 13 Open-market sale · S −2,998,908 $0.06 −$180K 13,005,169
Yk Bioventures Opportunities Gp I, Llc 10% owner Dec 12 Open-market sale · S −1,614,541 $0.07 −$113K 16,004,077
Yk Bioventures Opportunities Gp I, Llc 10% owner Dec 11 Open-market sale · S −1,343,801 $0.08 −$108K 17,618,618
Yk Bioventures Opportunities Gp I, Llc 10% owner Dec 10 Open-market sale · S −1,570,947 $0.09 −$141K 18,962,419
Yk Bioventures Opportunities Gp I, Llc 10% owner Dec 09 Open-market sale · S −850,543 $0.11 −$93.6K 20,533,366
Yk Bioventures Opportunities Gp I, Llc 10% owner Dec 06 Open-market sale · S −1,236,874 $0.12 −$148K 21,383,909
Yk Bioventures Opportunities Gp I, Llc 10% owner Oct 10 Open-market sale · S −3,250,000 $0.10 −$325K 22,620,783
Laporte Kathleen Director Sep 25 Exercise / conversion · M +965,997 — — 965,997
Sloan Stuart M 10% owner Sep 25 Open-market sale · S −532,486 $0.10 −$55.5K 21,067,956
Atwood Brian G Director Sep 25 Exercise / conversion · M +19,358,578 — — 19,607,313
Ehrlich Christopher B Interim Chairman and CEO Sep 25 Exercise / conversion · M +5,312,983 — — 5,791,808
Kosacz Barbara Director Feb 14 Other Transaction · J +5,828 — — 5,828
Phoenix Biotech SPONSOR, Llc 10% owner Feb 14 Other Transaction · J −4,171,246 — — 1,000,000
Phoenix Biotech SPONSOR, Llc 10% owner Feb 14 Other Transaction · J −1,125,000 — — 4,171,246
Fisher Douglas President Feb 14 Other Transaction · J +43,300 — — 43,300
Loewy Caroline M Director Feb 14 Other Transaction · J +5,828 — — 5,828
Geffken Daniel E Chief Financial Officer Feb 14 Other Transaction · J +10,002 — — 10,002
Atwood Brian G Chief Executive Officer Feb 14 Other Transaction · J +148,208 — — 248,735
Atwood Brian G Chief Executive Officer Feb 14 Other Transaction · J +100,527 — — 100,527

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support